3) PML-RARα fusion protein
PML-RARα融合蛋白
1.
5 μmol/L As2O3 was incubated for 24 hours and 48 hours,then total protein was extracted,expressions of subunit β1 and PML-RARα fusion protein were determined by Western blot.
5μmol/LAs2O3干预NB4细胞,分别提取干预24小时及48小时后的总蛋白;以Western blot检测蛋白酶体β1亚基及PML-RARα融合蛋白表达变化,并进行灰度分析。
4) delection NLS cap protein
去除NLS Cap蛋白
5) PML-RARα gene
PML-RARα基因
1.
Aim: To construct a eukaryotic coexpression plasmid containing PML-RARα gene and human GM-CSF(hGM-CSF) gene,which was expected to be used as a modified DNA vaccine for acute promyelocytic leukemia.
目的:构建急性早幼粒细胞白血病(APL)PML-RARα基因与人粒巨噬细胞集落刺激因子(hGM-CSF)基因真核双表达载体,为利用DNA疫苗治疗APL奠定基础。
2.
Objective To construct the PML-RARα gene recombinant plasmid, which is expected to be used as a modified DNA vaccine for acute promyelocytic leukemia.
目的构建PML-RARα基因重组表达质粒,为发展PML-RARα基因疫苗提供实验依据。
6) PML-RARα peptide
PML-RARα多肽
1.
Objective To investigate the specific cytotoxicity of T cells from cord blood induced by PML-RARα peptide and NB4 cells in vitro.
目的了解PML-RARα多肽和NB4细胞体外诱导体外诱导增殖的T细胞的特异性细胞毒作用。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条